The Recall Desk
CriticalFDA (Drugs)·D-0332-2026·Announced 2026-02-11

Rheumacare capsules recalled after the product was found to contain lead

Handelnine Global is recalling four bottles of Rheumacare capsules after the product was found to contain lead.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: Scored 5 because the FDA has classified this action as Class I, which the rubric maps directly to Critical.

Plain-English summary

Rheumacare capsules, in 30-count bottles, manufactured in India by Virgo UAP Pharma Pvt. Ltd. of Ahmedabad, under UPC 8 904218 700313, are being recalled by Handelnine Global LLC.

The reason given in the enforcement record is CGMP deviations: the product was found to contain lead.

The record lists 4 bottles of 30 capsules each, from lot CAM040, expiry 06/30/2029, and lot CAL079-N, expiry 09/30/2028. The record states the product was distributed to one customer in New York. The FDA has classified the action as Class I, its most serious category.

Consumers who have this product should stop taking it and should follow the seller's return instructions.

The recalled product

Product
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
Manufacturer
HANDELNINE GLOBAL LLC
Category
Drug — Herbal supplement
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot: CAM040
  • Exp. 06/30/2029 Lot: CAL079-N
  • Exp. 09/30/2028

Distribution

Distributed in 1 state:

Related recalls

Same hazard · lead

See all →